Skip to search formSkip to main contentSkip to account menu

ME3738

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Oleanolic Acid
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Clinical efficacy of combination therapy with ME3738 and pegylated interferon‐alpha‐2a in patients with hepatitis C virus genotype 1
ME3738, a derivative of soyasapogenol B, enhances the anti‐hepatitis C virus (HCV) effect of interferon in an in vitro… 
2011
2011
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
2008
2008
Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats
2007
2007
Effect of the inducer of interleukin-6 (ME3738) on rat liver treated with ethanol.
BACKGROUND Recently, ME3738, a derivative of soyasapogenol B, was developed as an inducer of interleukin (IL)-6. It has been… 
2007
2007
ME3738 protects against lithocholic acid-induced hepatotoxicity, which is associated with enhancement of biliary bile acid and cholesterol output.
2007
2007
[694] ME3738 PREVENTS ACETAMINOPHEN-INDUCED LIVER INJURY IN MICE VIA PROTECTION AGAINST MITOCHONDRIA!. PERMEABILITY TRANSITION
2006
2006
Protective effects of alpha1-acid glycoprotein and serum amyloid A on concanavalin A-induced liver failure via interleukin-6 induction by ME3738.
2002
2002
ME3738 protects from Con-A induced liver failure via an IL6-dependent mechanism
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)